123 related articles for article (PubMed ID: 15090140)
21. Chemical genetic approaches to kinase drug discovery.
Gallion SL; Qian D
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):638-45. PubMed ID: 16159026
[TBL] [Abstract][Full Text] [Related]
22. Drug targeting via retrometabolic approaches.
Bodor N; Buchwald P
Pharmacol Ther; 1997; 76(1-3):1-27. PubMed ID: 9535166
[TBL] [Abstract][Full Text] [Related]
23. Structure-based calculation of drug efficiency indices.
Hetényi C; Maran U; García-Sosa AT; Karelson M
Bioinformatics; 2007 Oct; 23(20):2678-85. PubMed ID: 17804436
[TBL] [Abstract][Full Text] [Related]
24. Aptamers and aptazymes: accelerating small molecule drug discovery.
Burgstaller P; Jenne A; Blind M
Curr Opin Drug Discov Devel; 2002 Sep; 5(5):690-700. PubMed ID: 12630289
[TBL] [Abstract][Full Text] [Related]
25. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
Rajamani R; Good AC
Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
[TBL] [Abstract][Full Text] [Related]
26. Structure-based development of target-specific compound libraries.
Orry AJ; Abagyan RA; Cavasotto CN
Drug Discov Today; 2006 Mar; 11(5-6):261-6. PubMed ID: 16580603
[TBL] [Abstract][Full Text] [Related]
27. Binding site detection and druggability index from first principles.
Seco J; Luque FJ; Barril X
J Med Chem; 2009 Apr; 52(8):2363-71. PubMed ID: 19296650
[TBL] [Abstract][Full Text] [Related]
28. Molecular modeling of hydration in drug design.
Mancera RL
Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
[TBL] [Abstract][Full Text] [Related]
29. Small molecule microarray-facilitated screening of affinity-based probes (AfBPs) for gamma-secretase.
Shi H; Liu K; Xu A; Yao SQ
Chem Commun (Camb); 2009 Sep; (33):5030-2. PubMed ID: 19668839
[TBL] [Abstract][Full Text] [Related]
30. Biophysical techniques for ligand screening and drug design.
Renaud JP; Delsuc MA
Curr Opin Pharmacol; 2009 Oct; 9(5):622-8. PubMed ID: 19581126
[TBL] [Abstract][Full Text] [Related]
31. Screening for selective small molecule inhibitors of the proteasome using activity-based probes.
Bogyo M
Methods Enzymol; 2005; 399():609-22. PubMed ID: 16338384
[TBL] [Abstract][Full Text] [Related]
32. Protein-protein interactions as targets for small molecule drug discovery.
Fry DC
Biopolymers; 2006; 84(6):535-52. PubMed ID: 17009316
[TBL] [Abstract][Full Text] [Related]
33. Mining the active proteome in plant science and biotechnology.
Kołodziejek I; van der Hoorn RA
Curr Opin Biotechnol; 2010 Apr; 21(2):225-33. PubMed ID: 20197235
[TBL] [Abstract][Full Text] [Related]
34. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes.
Blum G; von Degenfeld G; Merchant MJ; Blau HM; Bogyo M
Nat Chem Biol; 2007 Oct; 3(10):668-77. PubMed ID: 17828252
[TBL] [Abstract][Full Text] [Related]
36. The use of protein-ligand interaction fingerprints in docking.
Brewerton SC
Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
[TBL] [Abstract][Full Text] [Related]
37. Structural basis of the drug-binding specificity of human serum albumin.
Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
[TBL] [Abstract][Full Text] [Related]
38. A small molecule-kinase interaction map for clinical kinase inhibitors.
Fabian MA; Biggs WH; Treiber DK; Atteridge CE; Azimioara MD; Benedetti MG; Carter TA; Ciceri P; Edeen PT; Floyd M; Ford JM; Galvin M; Gerlach JL; Grotzfeld RM; Herrgard S; Insko DE; Insko MA; Lai AG; Lélias JM; Mehta SA; Milanov ZV; Velasco AM; Wodicka LM; Patel HK; Zarrinkar PP; Lockhart DJ
Nat Biotechnol; 2005 Mar; 23(3):329-36. PubMed ID: 15711537
[TBL] [Abstract][Full Text] [Related]
39. MASPIT: three-hybrid trap for quantitative proteome fingerprinting of small molecule-protein interactions in mammalian cells.
Caligiuri M; Molz L; Liu Q; Kaplan F; Xu JP; Majeti JZ; Ramos-Kelsey R; Murthi K; Lievens S; Tavernier J; Kley N
Chem Biol; 2006 Jul; 13(7):711-22. PubMed ID: 16873019
[TBL] [Abstract][Full Text] [Related]
40. Protein-protein interactions as targets for small-molecule therapeutics in cancer.
White AW; Westwell AD; Brahemi G
Expert Rev Mol Med; 2008 Mar; 10():e8. PubMed ID: 18353193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
